
ADM · NYSE
Reports Nov 3, 2026.
Consensus is $1.52 EPS for Sep 2026 across 2 estimates, ranging $1.49 to $1.56.
No consensus figures are on file, so the quarter cannot be assessed against an analyst estimate. Reported revenue was $6.386B, versus $6.341B in Q2 FY2025, while net income rose sharply to $0.91B from $0.22B. Ag Services and Oilseeds carried the revenue performance, increasing to $17.916B from $16.269B, with gains in Ag Services, Crushing, and Refined Products and Other. Carbohydrate Solutions was slightly lower at $2.757B versus $2.792B, as Starches and Sweeteners and Vantage Corn Processors both declined. Nutrition also dragged, falling to $1.902B from $1.993B, with declines in both Human Nutrition and Animal Nutrition. Revenue growth was modest in the quarter compared with the much larger year-over-year improvement in net income. The supplied material provides no operating, gross, or net margin figures, so margin direction and its causes cannot be evaluated. Six-month revenue was $43.171B, up from $41.341B.
No management guidance was supplied in the material. There are no forward revenue, earnings, segment-profit, margin, capital-expenditure, or cash-flow ranges for the next quarter or full year, and therefore no prior guide against which to compare the outlook. The filing provides historical quarterly and six-month revenue by segment, plus disclosures about commodity derivatives and valuation inputs, but it does not attach assumptions for commodity prices, volumes, freight, demand, currency, or operating costs to future periods. Any assessment of the periods ahead would therefore rely on historical results rather than a company-provided forecast.